KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Gains from Sales and Divestitures (2018 - 2022)

Petmed Express has reported Gains from Sales and Divestitures over the past 5 years, most recently at $99000.0 for Q1 2022.

  • For Q1 2022, Gains from Sales and Divestitures fell 21.43% year-over-year to $99000.0; the TTM value through Mar 2022 reached $99000.0, down 21.43%, while the annual FY2022 figure was $99000.0, 21.43% down from the prior year.
  • Gains from Sales and Divestitures for Q1 2022 was $99000.0 at Petmed Express, down from $126000.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $126000.0 in Q1 2021 and troughed at $114.0 in Q1 2018.
  • A 5-year average of $82822.8 and a median of $99000.0 in 2022 define the central range for Gains from Sales and Divestitures.
  • Biggest five-year swings in Gains from Sales and Divestitures: skyrocketed 101654.39% in 2019 and later plummeted 37.07% in 2020.
  • Year by year, Gains from Sales and Divestitures stood at $114.0 in 2018, then skyrocketed by 101654.39% to $116000.0 in 2019, then plummeted by 37.07% to $73000.0 in 2020, then skyrocketed by 72.6% to $126000.0 in 2021, then fell by 21.43% to $99000.0 in 2022.
  • Business Quant data shows Gains from Sales and Divestitures for PETS at $99000.0 in Q1 2022, $126000.0 in Q1 2021, and $73000.0 in Q1 2020.